Precision Biosciences (DTIL) Revenue Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3,790.58% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 37,272.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,272.41% |
| Dec 31, 2025 | 5,261.13% |
| Sep 30, 2025 | -97.74% |
| Jun 30, 2025 | -99.96% |
| Mar 31, 2025 | -99.84% |
| Dec 31, 2024 | -90.93% |
| Sep 30, 2024 | -95.61% |
| Jun 30, 2024 | 152.15% |
| Mar 31, 2024 | 100.27% |
| Dec 31, 2023 | -33.59% |
| Sep 30, 2023 | 78.19% |
| Jun 30, 2023 | 418.04% |
| Mar 31, 2023 | 164.70% |
| Dec 31, 2022 | 67.19% |
| Sep 30, 2022 | -69.37% |
| Jun 30, 2022 | -94.45% |
| Mar 31, 2022 | -79.71% |
| Dec 31, 2021 | -28.34% |
| Sep 30, 2021 | 226.44% |
| Jun 30, 2021 | 6,282.65% |
| Mar 31, 2021 | 133.62% |
| Dec 31, 2020 | 35.63% |
| Sep 30, 2020 | 51.35% |
| Jun 30, 2020 | -80.00% |
| Mar 31, 2020 | 28.12% |
| Dec 31, 2019 | 32.02% |
| Sep 30, 2019 | 91.46% |
| Jun 30, 2019 | 187.57% |
| Mar 31, 2019 | 257.46% |